Devinder Gill

144 papers receiving 5.5k citations

Devinder Gill's Hit Papers

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial 2018 · 393 citations
3930+5+10Years since publication2505007501000

Peers

Devinder Gill
Comparison fields: 5 of 124
  • Pathology and Forensic Medicine 2.4k
  • Genetics 1.3k
  • Oncology 2.2k
  • Hematology 827
  • Immunology 997
Replace Swaminathan P. Iyer with:
Swaminathan P. Iyer United States
Daan Dierickx Belgium
Guillaume Cartron France
Antonio J Grillo-López United States
John M. Pagel United States
Christian Buske Germany
Malik E. Juweid United States
Kengo Takeuchi Japan
Peter Reichardt Germany
Paolo Corradini Italy
Devinder Gill relative to Swaminathan P. Iyer United States Swaminathan P. Iyer's profile →
Citations per field
00.5×1.5×
Swaminathan P. Iyer · 1×
Citations per year

Countries citing papers authored by Devinder Gill

Since Specialization
Citations

This map shows the geographic impact of Devinder Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devinder Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devinder Gill more than expected).

Fields of papers citing papers by Devinder Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devinder Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devinder Gill. The network helps show where Devinder Gill may publish in the future.

Co-authors

The 25 scholars most cited alongside Devinder Gill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Devinder Gill Line = papers co-authored together Devinder Gill links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
Hit paper breakdown →
20101163
2
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2018393
3 2009236
4 2006213
5 2012199
6 2015196
7 2019145
8 2010144
9 2007126
10 2002102
11 200695
12 201689
13 201285
14 202284
15 199477
16 200372
17 201371
18 200670
19 201568
20 197566

About Devinder Gill

Devinder Gill is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Molecular Biology, having authored 148 papers that have together received 5.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (55 papers), Chronic Lymphocytic Leukemia Research (45 papers), Viral-associated cancers and disorders (15 papers), Acute Lymphoblastic Leukemia research (12 papers), Photorefractive and Nonlinear Optics (11 papers), Immune Cell Function and Interaction (10 papers), Acute Myeloid Leukemia Research (9 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.4k citations), Genetics (1.3k citations), Oncology (2.2k citations), Hematology (827 citations) and Immunology (997 citations). Devinder Gill has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Marek Trněný, Craig H. Moskowitz, Nicolas Mounier, Norbert Schmitz, Josette Brière, Ofer Shpilberg, Christian Gisselbrecht, David C. Linch, Nicolas Ketterer and Paula Marlton. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Journal of the American Chemical Society and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact